Regeneron
REGNSend this update
Regeneron layoffs
People who work here
Verify a work email, then post with no name. A poll you start shows in the thread list. It stays open for 3 days unless you pick 1 or 7, and you can close it sooner. A private reply goes to Messages.
Loading…
People in this kind of work also look at
Ask someone who worked here
Ask for a reference, or what the job is really like. The reply goes to a private inbox. Your name stays off this page.
Loading…
Email me about Regeneron
Sign up first. We email the address on that account when a new WARN filing or layoff report is linked to Regeneron.
Checking account…Mail about more than this one employer is Premium: saved WARN searches and a weekly digest. Turn off or switch the employer email from your account.
Where to file if this is your employer
No WARN notice is linked to Regeneron yet. The email alert is how you'll hear when one is.
13.0K
$904.94
▲ 0.23%
None
0
Low
H-1B base pay
Oct 2025 – Jun 2026$157,198
Median base · 328 filings
Middle half of filings
- Biochemists and Biophysicists60$136,337
- Molecular and Cellular Biologists31$144,750
- Natural Sciences Managers30$222,247
- Clinical Data Managers24$169,770
Tarrytown, NY (213) · Warren, NJ (47) · Sleepy Hollow, NY (19)
Base wage on public H-1B filings, filed as Regeneron Pharmaceuticals, Inc.. Stock and bonus are not included. U.S. Department of Labor, LCA disclosure
AI Layoff Impact Summary
AI-poweredRegeneron has no layoff events on record. WARN filings indicate no active notices. Low risk — company appears stable.
All Posts
Everything in one feed
Anyone else noticing the attrition spike?
I’ve been tracking our internal directory and it feels like people are jumping ship at an alarming rate lately. Some of these are long-tenured folks who you’d never expect to leave. When people who have been here 5+ years start heading for the exit, it’s usually a canary in the coal mine. I heard rumors during lunch that a few senior managers are looking elsewhere too. If the leadership is starting to bail, what does that say about the next two quarters? I’m starting to get that pit in my stomach again. Every time we have an All-Hands, I’m waiting for the 'tough decisions' announcement, but they keep pushing the narrative that we are in a 'growth phase.' If we are growing, why does it feel like we are constantly backfilling critical roles with contractors instead of full-time hires? Something isn't adding up. If you're a manager reading this, are you seeing signs of a formal layoff list being prepared, or are we just reading too much into the normal post-earnings-call austerity?
Quiet internal restructuring? Anyone else seeing this?
Is it just me, or has the vibe in the office shifted drastically over the last few weeks? I’ve noticed a lot of 'strategic realignments' being mentioned in department meetings, but nobody will give a straight answer about what it means for headcount. Management keeps using the 'efficiency' buzzword, which usually sends a chill down my spine. My team just had our travel and discretionary budgets slashed to zero without explanation. We’ve been told it’s to 'prioritize core pipeline development,' but we all know what that sounds like. I’ve been here for years, and I’ve never felt this much anxiety lingering in the hallways. Is anyone else noticing their project timelines being pulled forward aggressively, or is that just my specific group? Seems like they are squeezing every drop of productivity out of us before making a move. I’m polishing my resume tonight just in case. Does anyone have an inside track on whether they are actually planning a RIF, or are they just trying to scare us into working more hours?
Feeling the pressure to do more with less
It feels like the goalposts for our project milestones moved again this month, yet the headcount remains stagnant. We’re being told to 'accelerate timelines' without any additional support. I honestly feel like management is trying to force people to burn out so they can save on severance packages later. Every week there’s another meeting about 'synergy' and 'efficiency.' It’s the same vibe I saw at my last pharma company about six months before they initiated a massive wave of layoffs. Maybe I’m just being paranoid, but the energy in the office is definitely off. Does anyone know if they are still doing those 'voluntary' exit packages, or are they just squeezing us until we leave on our own? The constant anxiety is making it impossible to focus on the actual science.
Is the Tarrytown hiring freeze a prelude to something bigger?
Has anyone else noticed how quiet things have been on the internal job board lately? I’ve been trying to move internally to get away from my current manager, but everything seems to be locked down tight. There’s a lot of chatter in the halls about 'optimizing our portfolio' and 'focusing on key assets,' which usually sounds like corporate-speak for trimming the fat. I’ve seen some of our contractor renewals get delayed or outright denied in the last few weeks. Is leadership just playing it safe ahead of the next earnings call, or are we looking at a genuine reduction in force? My team feels like we're walking on eggshells. If anyone has intel from the directors or hears anything during the skip-level meetings, please drop a hint here. I’m just trying to figure out if I should start polishing the resume now or wait until the next town hall.
Regeneron: Performance reviews and 'right-sizing' worries
It’s that time of year again where the anxiety about calibration meetings hits its peak. I’ve been hearing rumors that they are using the performance review process as a way to quietly exit people without labeling it a formal RIF. If you’re placed in a certain bucket, does it feel like there’s actually a pathway to improvement, or is it just the first step toward being shown the door? My team is terrified. We’re being asked to hit impossible KPIs despite having zero headcount support for the open roles on our team. It feels like a setup to force people out through burnout or bad ratings. I’ve been through 'restructures' before, and the pattern is always the same: first, they squeeze the productivity, then they start trimming the headcount to 'optimize operational efficiency.' If you see your management acting overly critical of minor administrative tasks that they never cared about before, watch your back. I’m curious if anyone else has been told that their department budget is being 're-evaluated' for 2025. This place used to feel like a stable home, but the culture is shifting toward something much colder.
Regeneron: Any word on Q4 restructuring rumors?
Has anyone heard anything concrete lately? I’ve been hearing whispers from a few VPs about a 'streamlining' initiative hitting the R&D side before the end of the year. My manager has been acting weird during our 1:1s, almost like they aren't allowed to tell me what’s coming down the pipe. I know we didn't have a massive layoff event like some of our peers earlier this year, but the atmosphere feels off. Projects that were supposed to be high priority are suddenly having their budgets frozen or indefinitely paused. It feels like the calm before the storm. Is anyone else seeing a sudden slowdown in hiring for backfills in their departments, or is it just my site? I'm honestly just trying to gauge if I should polish my resume now or wait until after the Q4 financial call. I’ve been here for a few years and usually, I can read the room pretty well, but this feels different—less about individual performance and more about a top-down mandate. If anyone has intel on specific departments being targeted, please share. Not looking to panic, just looking for some transparency that we aren't getting from the top.
Regeneron: Bonus payout concerns and rumors
With the latest fiscal updates, I’m starting to wonder if the company is going to try and save cash by squeezing the bonus pool this year. Usually, this place is pretty solid with compensation, but the chatter in the hallways is all about 'budget optimizations' and 'fiscal responsibility.' I know a few people who have had their project budgets slashed without much explanation. If they aren't planning a RIF, are they just planning on freezing raises and cutting into our total comp to balance the books? It feels like we’re being conditioned for bad news. If anyone has heard anything about the upcoming performance review cycle or if the usual metrics are changing, please share. I’d hate to be blindsided after putting in 60-hour weeks for the last six months.
Regeneron: Is the 'strategic shift' just code for headcounts?
Is anyone else getting a weird vibe during the town halls lately? Leadership keeps using these buzzwords about 'streamlining operations' and 'focusing on core pipeline assets,' which usually means they’re looking for places to trim the fat. I’ve been in Tarrytown for five years, and the atmosphere feels different—less like we’re growing and more like we’re bracing for impact. I've noticed a few senior managers being much quieter than usual, and the backlog on new projects is suspiciously empty. Are there any whispers about potential restructuring coming down the pipeline for Q3 or Q4? I’m trying to decide if it’s time to start polishing the resume or if I’m just being paranoid. Any insights from R&D or Ops would be appreciated.
Regeneron: Anyone else feeling the pressure?
Lately, there's been a palpable sense of 'calm before the storm' around here. Metrics are being pushed harder, project timelines feel more rigid, and there's a lot of talk about 'efficiency improvements' from leadership. It's not outright panic, but the undercurrent is definitely there. I've seen a few key people leave suddenly in the last month, and no one is rushing to replace them. It makes you wonder if some departments are being prepped for a trim. Just trying to gauge the general sentiment. Is it just me, or does anyone else feel like things are tightening up significantly?
Regeneron: What's going on with hiring freezes?
Has anyone else noticed a significant slowdown in external hiring at Regeneron lately? My team has had an approved headcount for months, but the process has stalled out completely. HR is giving vague answers about 'internal alignment' and 'budget reviews.' It feels like more than just standard budget cycles. My contacts in other departments are saying similar things – roles that were open are now being put on hold indefinitely, and even internal transfers are getting really scrutinized. Doesn't feel like the rapid growth phase anymore. Anyone else hearing whispers or experiencing this? Curious if this is widespread or just a few departments getting hit.
Regeneron: Rumblings about restructuring?
Has anyone else heard any whispers about potential restructuring happening at Regeneron? I've been hearing some vague chatter through the grapevine, mostly around operational efficiencies and potential team consolidations. Nothing concrete, of course, but the rumors are persistent enough that I'm starting to wonder if there's smoke there. My role hasn't felt threatened personally, but the general atmosphere feels a bit tense lately. Managers seem a bit more stressed, and there's a noticeable lack of clarity on some strategic decisions. Curious if anyone has any more direct information or has experienced anything similar in the past during these types of situations. Just trying to prepare myself mentally.
Regeneron: Unusual silence on new projects?
Hey all, been at Regeneron for a few years now and things feel... quieter than usual. Not hearing much buzz about new initiatives or project kickoffs in my department, and even the usual internal job postings seem to have dried up a bit. Is anyone else getting this vibe? My manager is being super tight-lipped, which is also a bit unusual. Just trying to get a sense of the overall mood and whether others are seeing similar trends. Trying not to jump to conclusions, but the lack of information is starting to make me a little uneasy. Any insights or similar experiences would be appreciated. Just want to understand if this is a wider trend or if I'm overthinking it.
Regeneron: Anyone else notice hiring freezes or slowdowns?
Been trying to get a few roles filled on my team for a while now and it's been a struggle. It feels like approvals are taking way longer than usual, and some requisitions that seemed straightforward have just gone quiet. On top of that, I've heard from a couple of people in other departments that they're not posting new roles, or that internal transfers are being put on hold. Is this something others are experiencing across Regeneron? Feels like a soft hiring freeze or at least a significant slowdown is happening. Curious if this is a company-wide thing or if it's just certain departments/projects. Trying to understand the broader picture here. Any insights would be appreciated.
Regeneron: Performance Review cycle and impact?
Hey everyone, feeling a bit anxious about how the upcoming performance reviews might play out. With the general economic climate and whispers about efficiency drives, I'm wondering if anyone else is anticipating a tougher review cycle this year. Are managers being told to be more critical? Are there any specific metrics being emphasized more than usual? I've always felt pretty solid in my role, but lately, there's been a noticeable undercurrent of 'belt-tightening' and increased scrutiny on expenditures, which makes me wonder if that translates to how individual performance is being evaluated. Just trying to get a sense of the mood and if others are feeling the same way. Trying not to overthink it, but it's hard not to when things feel a bit uncertain.
Regeneron: Anyone else feeling the pressure on budgets?
What's the deal with budgets at Regeneron lately? Seems like every request for new equipment, software, or even travel is getting scrutinized to an insane degree. My manager's been stonewalling on even minor purchases, saying we need to 'optimize existing resources' and 'demonstrate essentiality.' It's definitely a change from a few months ago when things felt a bit more free-flowing. I'm not hearing specific layoff talk, but this kind of tight-fisted approach to spending makes me nervous. Are other teams seeing this? Is it just my department or is there a company-wide push for cost-saving that nobody's talking about openly? Just trying to understand if this is a sign of things to come or just some temporary belt-tightening. Let me know if you're experiencing this too.
Regeneron: Anyone else seeing a shift in project timelines?
Hey everyone. Haven't seen any official news or chatter about layoffs at Regeneron, but I've noticed a strange vibe lately. A couple of my projects have had their timelines pushed back, not just by a week or two, but significantly. Management's explanations are a bit vague, something about 'strategic reprioritization' and 'resource allocation adjustments.' It's weird because we've been hitting our milestones. Just wondering if anyone else in other departments or R&D groups are experiencing similar delays or unexpected project shifts? Trying to gauge if this is an isolated thing or part of a broader, unannounced slowdown. My gut feeling is telling me something's up, but I can't put my finger on it. Curious to hear if others are seeing anything similar.
Regeneron: What's the deal with hiring freezes/slowdowns?
Anyone else notice that hiring has pretty much ground to a halt across most departments? I know a few roles that were open for months and then just quietly disappeared from the careers page. And for the roles that are still posted, the interview process feels like it's taking forever, with lots of back-and-forth delays. It's not just in my department; I've heard similar stories from friends in other areas too. Feels like budgets are being tightened up, even if they aren't saying anything officially about layoffs. I'm wondering if this is a company-wide strategy shift, or if it's more sector-specific given the current biotech climate. Curious to hear if others are experiencing this and what insights they might have. Is this a sign of things to come, or just a temporary adjustment?
Regeneron: Rumblings of change? Anyone else picking up on this?
Hey everyone, long-time lurker here, first-time poster. I've been with Regeneron for a few years now, and lately, I've been getting a weird vibe. It's not anything concrete, no official announcements or anything like that, but there's a subtle shift in the air. Project timelines seem a bit more fluid, some internal communications feel a little more guarded, and there's a general sense of people watching their backs more than usual. I'm in a non-R&D role, so I'm not seeing the typical biotech layoff indicators directly related to pipeline issues. It just feels like... a slowdown? Or maybe a reallocation of resources? Just wanted to see if anyone else has been feeling this and if there's any internal chatter I might be missing. Trying not to overthink it, but the uncertainty is starting to get to me.
Regeneron: Just me or is the future feeling uncertain?
Been with Regeneron for a while and generally felt pretty secure. But lately, especially with the market conditions and some of the blockbuster drug lifecycle stuff people are talking about, I'm starting to feel a little uneasy. It's not like there are official announcements or anything, but you can just feel a shift. I've noticed a lot more 'strategy discussions' happening at higher levels, and some projects seem to be getting deprioritized or put on hold indefinitely. It's the kind of thing that doesn't directly impact my day-to-day yet, but it makes you wonder what's coming down the pipeline. Are they consolidating, pivoting, or just tightening the belt before a potential downturn? Curious if anyone else, particularly those in senior roles or with visibility into strategic planning, has any thoughts or observations? Is this just the normal biotech cycle, or is there something specific brewing at Regeneon that we should be aware of? Trying to get a better sense of the company's direction and stability moving forward.
Regeneron: Anyone else feeling the pinch outside of R&D?
Hey everyone, Been at Regeneron for a few years now in a non-R&D role (think operations/support functions). Lately, the atmosphere feels... different. Not sure if it's just me or if others are picking up on it too. Been hearing more about budget reviews and 'efficiency drives' than usual. Meetings seem a bit more tense, and there's a general sense of watchfulness that wasn't there before. Has anyone else in areas like finance, HR, IT, or corporate functions noticed any changes in project scope, hiring freezes (even for roles that were previously open), or just a general slowdown in activity? Trying to gauge if this is a wider company trend or if my department is just going through a rough patch. It's hard to get a clear picture when things are so hush-hush. Just want to see if I'm overthinking things or if there's something more concrete happening. Appreciate any insights, even if it's just gut feelings.
Regeneron: Post-COVID restructuring whispers?
Curious if anyone else has picked up on any whispers about potential restructuring at Regeneron. It feels like a lot of companies are doing it post-pandemic as they reassess priorities and budgets. I haven't heard anything definitive or seen any official announcements, but there's a definite 'feeling' in the air across different departments. Project scopes seem to be tightening up in some areas, and there's a bit more scrutiny on expenses. Has anyone been in meetings where future organizational structures or resource allocation were discussed, even vaguely? Trying to get a sense of the broader landscape and if there's any strategy behind the current mood, or if it's just standard business cycle stuff. Any perspective is welcome.
Regeneron: What's the vibe in non-R&D departments?
Hey everyone, I've been seeing a lot of chatter here about R&D and potential shifts, but what's the atmosphere like for those of us in other areas? Thinking commercial, manufacturing, IT, HR, etc. Is anyone else feeling any unusual quietness, a slowdown in hiring, or just a general sense of 'wait and see'? My team hasn't had any direct conversations, but there's definitely an undercurrent of something, and I'm trying to gauge if it's just general industry noise or something more specific to Regeneron. Any insights from other departments would be super helpful, especially if you've heard anything concrete or even just anecdotal rumors. Trying to stay informed without creating unnecessary panic.
Regeneron R&D funding shifts - impact on roles?
Has anyone in R&D seen or heard about any significant shifts in project funding or prioritization? I've been hearing some chatter about certain therapeutic areas potentially getting less focus moving forward, and others getting a bigger push. This isn't a layoff report, just trying to understand the strategic direction and what it might mean for different R&D teams and roles long-term. My team's work is stable for now, but I'm always looking ahead. If key programs are being de-emphasized, it's natural to wonder about resource allocation and potential headcount adjustments down the line, even if it's not immediate cuts. It would be helpful to hear from others in R&D if they have insights into where the company is doubling down or pulling back. Trying to get a better picture of the landscape.
Anyone else feeling the jitters at Regeneron lately?
Just wanted to check in and see if anyone else is picking up on the same vibes I am. Haven't seen any official announcements, but there's been a definite shift in atmosphere around here over the past few months. More closed-door meetings, hiring freezes on certain teams, and just a general sense of 'what's next?' are starting to make me uneasy. I've been with the company for a while now, and it's usually pretty transparent, but lately, information feels a bit more guarded. I'm trying not to panic, but it's hard not to speculate when you see certain projects slowing down or hear hushed conversations. Has anyone else noticed similar things, or am I just overthinking it? Curious to hear if others are feeling the same way or if you've heard any whispers through the grapevine. Trying to stay grounded but also prepare for potential unknowns.
No more threads.